Search - tctmd.com

Displaying 201 - 220 of 246

Sort: Relevancy | Date

News Daily News

DUTCH PEERS Publicado: Los Stents liberadores de Zotarolimus y Everolimus de 3ª Generación son Equivalentes

February 12, 2014

News Conference News TCT 2013

LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD

October 30, 2013

News Daily News

EXECUTIVE: Xience Performs Well in Patients with Less Complex Multivessel Disease

October 15, 2013

News Daily News

EXECUTIVE: Xience Funciona Bien en Pacientes con Enfermedad Multivaso Menos Compleja

October 15, 2013

News Daily News

EXECUTIVE：依维莫司在治疗非复杂多支病变中效果良好

October 15, 2013

News Daily News

Contemporary ZES Perform Well in Treating In-Stent Restenosis

August 14, 2013

News Daily News

Un Estudio de los Resultados PCI a Gran Rscala Revela Mejoras con el Paso del Tiempo en EE.UU.

August 02, 2013

News Daily News

Large-Scale PCI Outcomes Study Shows Improvements Over Time in United States

August 02, 2013

News Daily News

Meta-Analysis: Increased MI Risk with Double Bifurcation Stenting Due in Part to Stent Thrombosis

July 24, 2013

News Daily News

Meta-análisis: Aumento del riesgo de IM con la colocación de stent doble en la bifurcación se debe en parte a la trombosis del stent

July 24, 2013

News Conference News EuroPCR 2013

Novel Stent Helps Treat Bifurcation Lesions in FIM Registry

Jason Kahn

May 22, 2013

News Daily News

BIOSOLVE-1 Shows Improvement in Paclitaxel-Eluting Bioabsorbable Stent

March 25, 2013

News Daily News

BIOSOLVE-1 Confirma la Mejora en los Stents Bioabsorbibles liberadores de Paclitaxel

March 25, 2013

News Conference News ACC 2013

Is Nobori NEXT? Biodegradable-Polymer DES Noninferior to EES

Jason Kahn

March 09, 2013

News Daily News

Real-World Equivalence Seen for Zotarolimus- and Everolimus-Eluting Stents

Caitlin E. Cox

December 26, 2012

News Daily News

Equivalencia en el Mundo Real Confirmada de los Stents liberadores de Zotarolimus y Everolimus

Caitlin E. Cox

December 26, 2012

News Daily News

Extended Dual Antiplatelet Therapy Lowers Death, MI Rates in DES Patients

Jason Kahn

December 05, 2012

News Industry News

Abbott Announces CE Mark and European Launch of Next-Generation XIENCE Xpedition™ Drug Eluting Stent

August 20, 2012

News Daily News

Meta-analysis: DES Acceptable but Not Trouble-Free for Left Main Disease

Caitlin E. Cox

August 16, 2012

News Daily News

Meta Análisis: Los SLF son Aceptables aunque No están Exentos de Problemas en la Enfermedad del Tronco Coronario Izdo

Caitlin E. Cox

August 16, 2012

Advertisement

DUTCH PEERS Publicado: Los Stents liberadores de Zotarolimus y Everolimus de 3ª Generación son Equivalentes

LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD

EXECUTIVE: Xience Performs Well in Patients with Less Complex Multivessel Disease

EXECUTIVE: Xience Funciona Bien en Pacientes con Enfermedad Multivaso Menos Compleja

EXECUTIVE：依维莫司在治疗非复杂多支病变中效果良好

Contemporary ZES Perform Well in Treating In-Stent Restenosis

Un Estudio de los Resultados PCI a Gran Rscala Revela Mejoras con el Paso del Tiempo en EE.UU.

Large-Scale PCI Outcomes Study Shows Improvements Over Time in United States

Meta-Analysis: Increased MI Risk with Double Bifurcation Stenting Due in Part to Stent Thrombosis

Meta-análisis: Aumento del riesgo de IM con la colocación de stent doble en la bifurcación se debe en parte a la trombosis del stent

Novel Stent Helps Treat Bifurcation Lesions in FIM Registry

BIOSOLVE-1 Shows Improvement in Paclitaxel-Eluting Bioabsorbable Stent

BIOSOLVE-1 Confirma la Mejora en los Stents Bioabsorbibles liberadores de Paclitaxel

Is Nobori NEXT? Biodegradable-Polymer DES Noninferior to EES

Real-World Equivalence Seen for Zotarolimus- and Everolimus-Eluting Stents

Equivalencia en el Mundo Real Confirmada de los Stents liberadores de Zotarolimus y Everolimus

Extended Dual Antiplatelet Therapy Lowers Death, MI Rates in DES Patients

Abbott Announces CE Mark and European Launch of Next-Generation XIENCE Xpedition™ Drug Eluting Stent

Meta-analysis: DES Acceptable but Not Trouble-Free for Left Main Disease

Meta Análisis: Los SLF son Aceptables aunque No están Exentos de Problemas en la Enfermedad del Tronco Coronario Izdo

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content